Articles producció científica> Medicina i Cirurgia

Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1

  • Identification data

    Identifier: imarina:5873595
    Handle: http://hdl.handle.net/20.500.11797/imarina5873595
  • Authors:

    Masana L, Zamora A, Plana N, Comas-Cufí M, Garcia-Gil M, Martí-Lluch R, Ponjoan A, Alves-Cabratosa L, Elosua R, Marrugat J, Dégano IR, Ramos R
  • Others:

    Author, as appears in the article.: Masana L, Zamora A, Plana N, Comas-Cufí M, Garcia-Gil M, Martí-Lluch R, Ponjoan A, Alves-Cabratosa L, Elosua R, Marrugat J, Dégano IR, Ramos R
    Department: Medicina i Cirurgia
    e-ISSN: 2077-0383
    URV's Author/s: Masana Marín, Luis / Plana Gil, Núria
    Keywords: Risk assessment Real-world data Primary-care Prevention Population-prevalence Management Incidence Familial hypercholesterolemia Diagnosis Cardiovascular diseases Atherosclerosis
    Abstract: In the statin era, the incidence of atherosclerotic cardiovascular diseases (ASCVD) in patients with familial hypercholesterolemia (FH) has not been updated. We aimed to determine the incidence of ASCVD in patients with FH-phenotype (FH-P) and to compare it with that of normal low-density lipoprotein cholesterol (LDL-C) patients. We performed a retrospective cohort study using the Database of the Catalan primary care system, including ≥18-year-old patients with an LDL-C measurement. From 1,589,264 patients available before 2009, 12,823 fulfilled FH-P criteria and 514,176 patients were normolipidemic (LDL-C < 115 mg/dL). In primary prevention, patients with FH-P had incidences of ASCVD and coronary heart disease (CHD) of 14.9/1000 and 5.8/1000 person-years, respectively, compared to 7.1/1000 and 2.1/1000 person-years in the normolipidemic group. FH-P showed hazard ratio (HR) of 7.1 and 16.7 for ASCVD and CHD, respectively, in patients younger than 35 years. In secondary prevention, patients with FH-P had incidences of ASCVD and CHD of 89.7/1000 and 34.5/1000 person-years, respectively, compared to 90.9/1000 and 28.2/1000 person-years in the normolipidemic group (HR in patients younger than 35 years: 2.4 and 6.0). In the statin era, FH-P remains associated with high cardiovascular risk, compared with the normolipidemic population. This excess of risk is markedly high in young individuals.
    Thematic Areas: Medicine, general & internal Medicine (miscellaneous) Medicine (all)
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    ISSN: 20770383
    Author's mail: nuria.plana@urv.cat luis.masana@urv.cat
    Author identifier: 0000-0002-4231-7618 0000-0002-0789-4954
    Record's date: 2023-05-20
    Journal volume: 8
    Papper version: info:eu-repo/semantics/publishedVersion
    Link to the original source: https://www.mdpi.com/2077-0383/8/7/1080
    Licence document URL: http://repositori.urv.cat/ca/proteccio-de-dades/
    Papper original source: Journal Of Clinical Medicine. 8 (7):
    APA: Masana L, Zamora A, Plana N, Comas-Cufí M, Garcia-Gil M, Martí-Lluch R, Ponjoan A, Alves-Cabratosa L, Elosua R, Marrugat J, Dégano IR, Ramos R (2019). Incidence of Cardiovascular Disease in Patients with Familial Hypercholesterolemia Phenotype: Analysis of 5 Years Follow-Up of Real-World Data from More than 1. Journal Of Clinical Medicine, 8(7), -. DOI: 10.3390/jcm8071080
    Article's DOI: 10.3390/jcm8071080
    Entity: Universitat Rovira i Virgili
    Journal publication year: 2019
    Publication Type: Journal Publications
  • Keywords:

    Medicine (Miscellaneous),Medicine, General & Internal
    Risk assessment
    Real-world data
    Primary-care
    Prevention
    Population-prevalence
    Management
    Incidence
    Familial hypercholesterolemia
    Diagnosis
    Cardiovascular diseases
    Atherosclerosis
    Medicine, general & internal
    Medicine (miscellaneous)
    Medicine (all)
  • Documents:

  • Cerca a google

    Search to google scholar